21 Jul 2017
Presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.
33 product(s) and free and sample content
Using a peer-reviewed methodology that provides robust, unbiased drug phase success rates and timeline metrics by treatment indication, Pharmapremia enables you to make strong, informed decisions about your drug development pipeline.
29 Jun 2017
Drill deeper into industry-standard data using peer-reviewed methodology to gain insights you can bank on. Pharmapremia can bring confidence to the accuracy of your benchmarks.
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
By Ljlal Syed, Mark Lansdell and David Abramson 19 Sep 2017
This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic
Topic Deal trends
By Colin White, Robert Jeng & Jolene Lau 19 Sep 2017
This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well
You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.
By Amanda Maxwell 27 Feb 2018
When will notified bodies be appointed? How many will there be? Where are the problem areas? And what are the resource issues? MedTech Europe's Oliver Bisazza answers these and many more critical questions.
By Bob Kronemyer 16 Feb 2018
Aiming to improve the lives of patients living with chronic, intractable pain, Australian startup Saluda Medical Pty Limited is the first and only neuromodulation company in the world to develop a closed-loop spinal cord stimulation system (SCS). Unlike other SCS systems marketed today, Saluda’s device, currently in clinical trials, is designed to measure the spinal cord’s response to electrical stimulation, and then respond to patient's preferred stimulation.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: